- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
I1DX34
SAO
Week ended 07 Aug 2026
Weekly Investor Report
IDEXX Laboratories, Inc. · Healthcare · Diagnostics & Research
Latest close
612.0 BRL
4.7%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 1.4% above the Trend Line and sits at 31.0% of its 52-week range. The latest completed week returned 4.7%, after a 6.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
42
out of 100
Latest Close
612.0 BRL
7 Aug 2026
1W Return
4.7%
latest completed week
4W Return
6.1%
short-term follow-through
12W Return
14.4%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 31.90% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.7%
Latest completed week; four-week move 6.1%.
Indicator stack
28/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 31.90%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
21 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 1.4% above the Trend Line and sits at 31.0% of its 52-week range. The latest completed week returned 4.7%, after a 6.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0912-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 6.1% over four weeks, 14.4% over 12 weeks, and -13.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.77Latest activity-pressure read.
Pressure change95.3%Four-week change in activity pressure.
Leadership-11.39Latest relative-leadership reading.
RS change45.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 21 relevant articles.
1 positive · 19 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-24.8%Distance below the 52-week high.
13-week volatility3.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2613 weeks finished lower.
Best week+6.8%Week of 10 Jul.
Worst week-6.3%Week of 6 Mar.
Latest week+4.7%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains7
Flat weeks2
Modest losses8
Sharp losses5
Recent vol3.5%13-week weekly-return volatility.
Base vol3.2%52-week weekly-return volatility.
Up/down split21/23Count of positive and negative weeks in the 52-week window.
Average skew2.7% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank20 / 82
Group average-0.7%
Trend breadth35.4%
Trend35.4%active weekly trend signals
MD65.9%positive activity pressure
RS46.3%positive relative leadership
Four-week leaders
IndustryBR Diagnostics & Research
4-week rank4 / 10
Group average4.4%
Trend breadth30.0%
Trend30.0%active weekly trend signals
MD90.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape36/100
Trend, activity pressure, participation, and risk combine to a 36/100 tape read.
Indicator analysis22/100Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.
Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 31.90%Next-week expectancy is negative with a 31.90% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 21 relevant articles.
IDEXX Laboratories Inc Stock Intrinsic Values Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 612.0 BRL | 4.7% | 603.5 BRL | 566.4 BRL | 0.77 | -11.39 | 100 | Off |
| 31 Jul 2026 | 584.5 BRL | 1.8% | 608.8 BRL | 565.7 BRL | 0.72 | -18.62 | 100 | Off |
| 24 Jul 2026 | 574.0 BRL | 4.8% | 614.4 BRL | 565.3 BRL | 0.47 | -18.72 | 27 | Off |
| 17 Jul 2026 | 547.8 BRL | -5.0% | 620.5 BRL | 565.1 BRL | 0.47 | -22.71 | 176 | Off |
| 10 Jul 2026 | 576.7 BRL | 6.8% | 627.7 BRL | 564.9 BRL | 0.39 | -21.00 | 330 | Off |
| 3 Jul 2026 | 540.0 BRL | -5.1% | 633.8 BRL | 564.5 BRL | 0.12 | -24.88 | 0 | Off |
| 26 Jun 2026 | 569.0 BRL | -1.5% | 641.6 BRL | 564.0 BRL | 0.05 | -20.81 | 211 | Off |
| 19 Jun 2026 | 577.6 BRL | 1.6% | 649.8 BRL | 563.2 BRL | -0.28 | -17.70 | 0 | Off |
| 12 Jun 2026 | 568.5 BRL | 0.0% | 656.7 BRL | 562.4 BRL | -0.57 | -20.49 | 0 | Off |
| 5 Jun 2026 | 568.5 BRL | 1.6% | 663.0 BRL | 561.7 BRL | -0.87 | -19.82 | 0 | Off |
| 29 May 2026 | 559.6 BRL | 1.5% | 669.4 BRL | 561.0 BRL | -1.02 | -23.56 | 11 | Off |
| 22 May 2026 | 551.4 BRL | 3.0% | 673.9 BRL | 560.4 BRL | -1.20 | -26.09 | 111 | Off |
| 15 May 2026 | 535.1 BRL | -2.8% | 678.6 BRL | 559.9 BRL | -1.27 | -29.07 | 2 | Off |
| 8 May 2026 | 550.6 BRL | -1.2% | 684.2 BRL | 559.5 BRL | -1.35 | -30.07 | 389 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.